705 related articles for article (PubMed ID: 29899017)
1. Statin Eligibility, Coronary Artery Calcium, and Subsequent Cardiovascular Events According to the 2016 United States Preventive Services Task Force (USPSTF) Statin Guidelines: MESA (Multi-Ethnic Study of Atherosclerosis).
Miedema MD; Dardari ZA; Kianoush S; Virani SS; Yeboah J; Knickelbine T; Sandfort V; Rodriguez CJ; Nasir K; Blaha MJ
J Am Heart Assoc; 2018 Jun; 7(12):. PubMed ID: 29899017
[TBL] [Abstract][Full Text] [Related]
2. CAC Score Improves Coronary and CV Risk Assessment Above Statin Indication by ESC and AHA/ACC Primary Prevention Guidelines.
Mahabadi AA; Möhlenkamp S; Lehmann N; Kälsch H; Dykun I; Pundt N; Moebus S; Jöckel KH; Erbel R;
JACC Cardiovasc Imaging; 2017 Feb; 10(2):143-153. PubMed ID: 27665163
[TBL] [Abstract][Full Text] [Related]
3. Subclinical Atherosclerosis, Statin Eligibility, and Outcomes in African American Individuals: The Jackson Heart Study.
Shah RV; Spahillari A; Mwasongwe S; Carr JJ; Terry JG; Mentz RJ; Addison D; Hoffmann U; Reis J; Freedman JE; Lima JAC; Correa A; Murthy VL
JAMA Cardiol; 2017 Jun; 2(6):644-652. PubMed ID: 28315622
[TBL] [Abstract][Full Text] [Related]
4. Statin Trials, Cardiovascular Events, and Coronary Artery Calcification: Implications for a Trial-Based Approach to Statin Therapy in MESA.
Mortensen MB; Falk E; Li D; Nasir K; Blaha MJ; Sandfort V; Rodriguez CJ; Ouyang P; Budoff M
JACC Cardiovasc Imaging; 2018 Feb; 11(2 Pt 1):221-230. PubMed ID: 28624395
[TBL] [Abstract][Full Text] [Related]
5. Implications of Coronary Artery Calcium Testing Among Statin Candidates According to American College of Cardiology/American Heart Association Cholesterol Management Guidelines: MESA (Multi-Ethnic Study of Atherosclerosis).
Nasir K; Bittencourt MS; Blaha MJ; Blankstein R; Agatson AS; Rivera JJ; Miedema MD; Sibley CT; Shaw LJ; Blumenthal RS; Budoff MJ; Krumholz HM
J Am Coll Cardiol; 2015 Oct; 66(15):1657-68. PubMed ID: 26449135
[TBL] [Abstract][Full Text] [Related]
6. American College of Cardiology/American Heart Association (ACC/AHA) Class I Guidelines for the Treatment of Cholesterol to Reduce Atherosclerotic Cardiovascular Risk: Implications for US Hispanics/Latinos Based on Findings From the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).
Qureshi WT; Kaplan RC; Swett K; Burke G; Daviglus M; Jung M; Talavera GA; Chirinos DA; Reina SA; Davis S; Rodriguez CJ
J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28495699
[TBL] [Abstract][Full Text] [Related]
7. Statin eligibility and cardiovascular risk burden assessed by coronary artery calcium score: comparing the two guidelines in a large Korean cohort.
Rhee EJ; Park SE; Oh HG; Park CY; Oh KW; Park SW; Blankstein R; Plutzky J; Lee WY
Atherosclerosis; 2015 May; 240(1):242-9. PubMed ID: 25818250
[TBL] [Abstract][Full Text] [Related]
8. Collective impact of conventional cardiovascular risk factors and coronary calcium score on clinical outcomes with or without statin therapy: The St Francis Heart Study.
Waheed S; Pollack S; Roth M; Reichek N; Guerci A; Cao JJ
Atherosclerosis; 2016 Dec; 255():193-199. PubMed ID: 27693004
[TBL] [Abstract][Full Text] [Related]
9. Statin Use in Primary Prevention of Atherosclerotic Cardiovascular Disease According to 5 Major Guidelines for Sensitivity, Specificity, and Number Needed to Treat.
Mortensen MB; Nordestgaard BG
JAMA Cardiol; 2019 Nov; 4(11):1131-1138. PubMed ID: 31577339
[TBL] [Abstract][Full Text] [Related]
10. Implications of the new American College of Cardiology/American Heart Association cholesterol guidelines for primary atherosclerotic cardiovascular disease event prevention in a multi ethnic cohort: Multi-Ethnic Study of Atherosclerosis (MESA).
Yeboah J; Sillau S; Delaney JC; Blaha MJ; Michos ED; Young R; Qureshi WT; McClelland R; Burke GL; Psaty BM; Herrington DM
Am Heart J; 2015 Mar; 169(3):387-395.e3. PubMed ID: 25728729
[TBL] [Abstract][Full Text] [Related]
11. Guideline-based statin/lipid-lowering therapy eligibility for primary prevention and accuracy of coronary artery calcium and clinical cardiovascular events: The Multi-Ethnic Study of Atherosclerosis (MESA).
Flueckiger P; Qureshi W; Michos ED; Blaha M; Burke G; Sandfort V; Herrington D; Yeboah J
Clin Cardiol; 2017 Mar; 40(3):163-169. PubMed ID: 27859433
[TBL] [Abstract][Full Text] [Related]
12. A Simple Disease-Guided Approach to Personalize ACC/AHA-Recommended Statin Allocation in Elderly People: The BioImage Study.
Mortensen MB; Fuster V; Muntendam P; Mehran R; Baber U; Sartori S; Falk E
J Am Coll Cardiol; 2016 Aug; 68(9):881-91. PubMed ID: 27561760
[TBL] [Abstract][Full Text] [Related]
13. Increases in statin eligibility to reduce cardiovascular risk according to the 2013 ACC/AHA cholesterol guidelines in the Africa Middle East region: a sub-analysis of the Africa Middle East Cardiovascular Epidemiological (ACE) study.
Hamoui O; Omar MI; Raal FJ; Rashed W; Kane A; Alami M; Abreu P; Mashhoud W; Alsheikh-Ali AA
BMC Cardiovasc Disord; 2019 Mar; 19(1):61. PubMed ID: 30876390
[TBL] [Abstract][Full Text] [Related]
14. Validation of the 2016 USPSTF recommendations for primary cardiovascular prevention in a large contemporary cohort.
Schonmann Y; Bleich O; Matalon A; Yeshua H
Eur J Prev Cardiol; 2018 May; 25(8):870-880. PubMed ID: 29517367
[TBL] [Abstract][Full Text] [Related]
15. Utility of Nontraditional Risk Markers in Individuals Ineligible for Statin Therapy According to the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines.
Yeboah J; Polonsky TS; Young R; McClelland RL; Delaney JC; Dawood F; Blaha MJ; Miedema MD; Sibley CT; Carr JJ; Burke GL; Goff DC; Psaty BM; Greenland P; Herrington DM
Circulation; 2015 Sep; 132(10):916-22. PubMed ID: 26224808
[TBL] [Abstract][Full Text] [Related]
16. Coronary Artery Calcium for Personalized Allocation of Aspirin in Primary Prevention of Cardiovascular Disease in 2019: The MESA Study (Multi-Ethnic Study of Atherosclerosis).
Cainzos-Achirica M; Miedema MD; McEvoy JW; Al Rifai M; Greenland P; Dardari Z; Budoff M; Blumenthal RS; Yeboah J; Duprez DA; Mortensen MB; Dzaye O; Hong J; Nasir K; Blaha MJ
Circulation; 2020 May; 141(19):1541-1553. PubMed ID: 32233663
[TBL] [Abstract][Full Text] [Related]
17. Comparing eligibility for statin therapy for primary prevention under 2022 USPSTF recommendations and the 2018 AHA/ACC/ multi-society guideline recommendations: From National Health and Nutrition Examination Survey.
Gupta K; Kakar TS; Jain V; Gupta M; Al Rifai M; Slipczuk L; Nambi V; Bittner V; Blumenthal RS; Stone NJ; Lavie CJ; Virani SS
Prog Cardiovasc Dis; 2022; 75():78-82. PubMed ID: 36038004
[TBL] [Abstract][Full Text] [Related]
18. Guideline-Based Statin Eligibility, Coronary Artery Calcification, and Cardiovascular Events.
Pursnani A; Massaro JM; D'Agostino RB; O'Donnell CJ; Hoffmann U
JAMA; 2015 Jul; 314(2):134-41. PubMed ID: 26172893
[TBL] [Abstract][Full Text] [Related]
19. Coronary artery calcium and carotid artery intima-media thickness for the prediction of stroke and benefit from statins.
Osawa K; Trejo MEP; Nakanishi R; McClelland RL; Blaha MJ; Blankstein R; McEvoy JW; Ceponiene I; Stein JH; Sacco RL; Polak JF; Budoff MJ
Eur J Prev Cardiol; 2018 Dec; 25(18):1980-1987. PubMed ID: 30183342
[TBL] [Abstract][Full Text] [Related]
20. Use of Statins for Primary Prevention: Selection of Risk Threshold and Implications Across Race and Gender.
Goyal A; Cooper HA; Aronow WS; Nagpal P; Yandrapalli S; Nabors CC; Frishman WH
Am J Med; 2018 Oct; 131(10):1234-1237. PubMed ID: 29928863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
